Equities analysts predict that Medidata Solutions Inc (NASDAQ:MDSO) will post earnings of $0.39 per share for the current fiscal quarter, Zacks Investment Research reports. Eight analysts have issued estimates for Medidata Solutions’ earnings. The highest EPS estimate is $0.42 and the lowest is $0.36. Medidata Solutions posted earnings per share of $0.43 in the same quarter last year, which would suggest a negative year-over-year growth rate of 9.3%. The company is expected to report its next quarterly earnings report on Tuesday, July 23rd.
On average, analysts expect that Medidata Solutions will report full-year earnings of $1.83 per share for the current year, with EPS estimates ranging from $1.77 to $1.88. For the next year, analysts anticipate that the firm will report earnings of $2.14 per share, with EPS estimates ranging from $2.00 to $2.27. Zacks’ EPS calculations are an average based on a survey of research firms that follow Medidata Solutions.
Medidata Solutions (NASDAQ:MDSO) last issued its earnings results on Tuesday, April 30th. The company reported $0.45 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.12 by $0.33. Medidata Solutions had a return on equity of 9.28% and a net margin of 7.99%. The business had revenue of $173.50 million during the quarter, compared to analyst estimates of $172.12 million. During the same quarter in the previous year, the firm earned $0.40 EPS. Medidata Solutions’s revenue was up 16.3% on a year-over-year basis.
Shares of NASDAQ:MDSO opened at $90.65 on Friday. Medidata Solutions has a fifty-two week low of $60.10 and a fifty-two week high of $98.60. The company has a quick ratio of 2.57, a current ratio of 2.57 and a debt-to-equity ratio of 0.29. The stock has a market capitalization of $5.66 billion, a price-to-earnings ratio of 94.43, a price-to-earnings-growth ratio of 8.25 and a beta of 1.42.
In related news, EVP Michael Pray sold 15,000 shares of the business’s stock in a transaction that occurred on Friday, March 1st. The stock was sold at an average price of $76.50, for a total transaction of $1,147,500.00. Following the completion of the transaction, the executive vice president now directly owns 77,134 shares in the company, valued at approximately $5,900,751. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, EVP Daniel Patrick Shannon sold 19,725 shares of the business’s stock in a transaction that occurred on Tuesday, March 12th. The shares were sold at an average price of $75.17, for a total value of $1,482,728.25. Following the transaction, the executive vice president now owns 70,497 shares of the company’s stock, valued at $5,299,259.49. The disclosure for this sale can be found here. Insiders own 4.70% of the company’s stock.
Large investors have recently made changes to their positions in the stock. Arcadia Investment Management Corp MI grew its stake in shares of Medidata Solutions by 1.1% during the 1st quarter. Arcadia Investment Management Corp MI now owns 56,141 shares of the company’s stock valued at $4,112,000 after acquiring an additional 600 shares during the period. Virginia Retirement Systems ET AL bought a new position in shares of Medidata Solutions during the 4th quarter valued at approximately $452,000. BlackRock Inc. grew its stake in shares of Medidata Solutions by 2.9% during the 4th quarter. BlackRock Inc. now owns 6,995,601 shares of the company’s stock valued at $471,644,000 after acquiring an additional 195,763 shares during the period. American International Group Inc. grew its stake in shares of Medidata Solutions by 1.9% during the 4th quarter. American International Group Inc. now owns 161,630 shares of the company’s stock valued at $10,897,000 after acquiring an additional 3,091 shares during the period. Finally, Janus Henderson Group PLC grew its stake in shares of Medidata Solutions by 6.0% during the 1st quarter. Janus Henderson Group PLC now owns 1,837,555 shares of the company’s stock valued at $134,583,000 after acquiring an additional 103,716 shares during the period.
About Medidata Solutions
Medidata Solutions, Inc provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development and commercialization of new therapies. The company's platform solutions include data capture and management, and trial planning and management.
Further Reading: What Is An Exchange-Traded Fund (ETF)?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.